PD Dr. med. Massimiliano Fusaro

Seit 11/2025 Leitender Arzt Interventionelle Kardiologie am Peter Osypka Herzzentrum München

Seit 2025
Belegarzt Zulassung am St Josef Krankenhaus Buchloe und Praxis Kardiologie und Angiologie Prof Dr. med. Michael Reppel.
Seit 2024
Oberarzt Interventionelle Kardiologie und Belegarzt am Benediktus Krankenhaus Tutzing
2021-2023
Chefarzt der Klinik für Innere Medizin, Kardiologie und Angiologie am Zollernalb-Klinikum GmbH, Albstadt
Chefarzt der Abteilung für Interventionelle Kardiologie am Klinik Vincentinum, Augsburg
2008-2021
Oberarzt für Interventionelle Kardiologie und Leiter des Programms für komplexe Koronar Interventionen sowie chronische Koronarverschlüsse (CHIP und CTO) am Deutschen Herzzentrum München (Prof. Dr. A. Schömig und Prof. Dr. H. Schunkert)
2003-2008
Oberarzt mit Schwerpunkt Herzkatheterlabor, an der Klinik für Kardiologie, am „Istituto Policlinico San Donato Milanese”, Mailand und Policlinico Abano Terme, Padua, Italien
1998-2003
Facharztausbildung an der Klinik für Innere Medizin und Kardiologie am Uniklinik Verona, Prof. Dr. Piero Zardini, Verona, Italien
1992-1998
Medizinstudium am Universitätsklinikum Verona, Italien

 Fachgesellschaften Mitgliedschaft
Deutschen Gesellschaft für Kardiologie (DGK) und Arbeitsgruppe Interventionelle Kardiologie (AGIK)
Europäischen Gesellschaft für Kardiologie und Perkutane Kardiovaskuläre Interventionen (EAPCI)

Ausgewählte Publikationen

Clinical and angiographic outcomes of crossing techniques for coronary chronic total occlusions: the ISAR-CTO registry.
Xhepa E, Cassese S, Ndrepepa G, Joner M, Kufner S, Aytekin A, Lahmann AL, Voll F, Fusaro M, Pinieck S, Schunkert H, Kastrati A, Fusaro M. EuroIntervention. 2021 Oct 1;17(8):e656-e663. doi: 10.4244/EIJ-D-20-01248. PMID: 33646124

Randomized Comparison of Paclitaxel-Eluting Balloon and Stenting Versus Plain Balloon Plus Stenting Versus Directional Atherectomy for Femoral Artery Disease (ISAR-STATH).
Ott I, Cassese S, Groha P, Steppich B, Hadamitzky M, Ibrahim T, Kufner S, Dewitz K, Hiendlmayer R, Laugwitz KL, Schunkert H, Kastrati A, Fusaro M. Circulation. 2017 Jun 6;135(23):2218-2226. doi: 10.1161/CIRCULATIONAHA.116.025329. Epub 2017 Apr 19.

Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis.
Xhepa E, Bresha J, Joner M, Hapfelmeier A, Rivero F, Ndrepepa G, Nano N, Cuesta J, Kufner S, Cassese S, Bastante T, Aytekin A, Rroku A, García-Guimaraes M, Lahmann AL, Pinieck S, Rai H, Fusaro M, Schunkert H, Pérez-Vizcayno MJ, Gonzalo N, Alfonso F, Kastrati A. EuroIntervention. 2021 Aug 6;17(5):e388-e395. doi: 10.4244/EIJ-D-20-00662. PMID: 32894230

Subintimal Versus Intraplaque Recanalization of Coronary Chronic Total Occlusions: Mid-Term Angiographic and OCT Findings From the ISAR-OCT-CTO Registry.
Xhepa E, Cassese S, Rroku A, Joner M, Pinieck S, Ndrepepa G, Kastrati A, Fusaro M. JACC Cardiovasc Interv. 2019 Oct 14;12(19):1889-1898. doi: 10.1016/j.jcin.2019.04.049. Epub 2019 Sep 11. PMID: 31521651 Free article.
10-Year Outcomes From a Randomized Trial of Polymer-Free Versus Durable Polymer Drug-Eluting Coronary Stents.
Kufner S, Ernst M, Cassese S, Joner M, Mayer K, Colleran R, Koppara T, Xhepa E, Koch T, Wiebe J, Ibrahim T, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A, Byrne RA; ISAR-TEST-5 Investigators. J Am Coll Cardiol. 2020 Jul 14;76(2):146-158. doi: 10.1016/j.jacc.2020.05.026.

Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial.
Mehilli J, Pache J, Abdel-Wahab M, Schulz S, Byrne RA, Tiroch K, Hausleiter J, Seyfarth M, Ott I, Ibrahim T, Fusaro M, Laugwitz KL, Massberg S, Neumann FJ, Richardt G, Schömig A, Kastrati A; Is Drug-Eluting-Stenting Associated with Improved Results in Coronary Artery Bypass Grafts? (ISAR-CABG) Investigators. Lancet. 2011 Sep 17;378(9796):1071-8. doi: 10.1016/S0140-6736(11)61255-5. Epub 2011 Aug 26. PMID: 21872918

Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials.
Xhepa E, Tada T, Kufner S, Ndrepepa G, Byrne RA, Kreutzer J, Ibrahim T, Tiroch K, Valgimigli M, Tölg R, Cassese S, Fusaro M, Schunkert H, Laugwitz KL, Mehilli J, Kastrati A. Catheter Cardiovasc Interv. 2017 Jan;89(1):1-10. doi: 10.1002/ccd.26645. Epub 2016 Aug 12. PMID:

Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site – CLOSURE device versus manual compression (ISAR-CLOSURE) trial.
Xhepa E, Byrne RA, Schulz S, Helde S, Gewalt S, Cassese S, Linhardt M, Ibrahim T, Mehilli J, Hoppe K, Grupp K, Kufner S, Böttiger C, Hoppmann P, Burgdorf C, Fusaro M, Ott I, Schneider S, Hengstenberg C, Schunkert H, Laugwitz KL, Kastrati A; ISAR-CLOSURE investigators. EuroIntervention. 2014 Jun;10(2):198-203. doi: 10.4244/EIJV10I2A33. PMID: 24952057
Diabetes mellitus and femoropopliteal in-stent restenosis.
Voll F, Wolf F, Ingwersen M, Kinstner CM, Kufner S, Ibrahim T, Ott I, Krankenberg H, Fusaro M, Cassese S. Vasa. 2022 Jul;51(4):247-255. doi: 10.1024/0301-1526/a001006. Epub 2022 May 11. PMID: 35543439 Free article.
Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease.
Mehilli J, Richardt G, Valgimigli M, Schulz S, Singh A, Abdel-Wahab M, Tiroch K, Pache J, Hausleiter J, Byrne RA, Ott I, Ibrahim T, Fusaro M, Seyfarth M, Laugwitz KL, Massberg S, Kastrati A; ISAR-LEFT-MAIN 2 Study Investigators. J Am Coll Cardiol. 2013 Dec 3;62(22):2075-82. doi: 10.1016/j.jacc.2013.07.044. Epub 2013 Aug 21. PMID: 23973699 Free article. Clinical Trial.
Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
Tada T, Byrne RA, Simunovic I, King LA, Cassese S, Joner M, Fusaro M, Schneider S, Schulz S, Ibrahim T, Ott I, Massberg S, Laugwitz KL, Kastrati A. JACC Cardiovasc Interv. 2013 Dec;6(12):1267-74. doi: 10.1016/j.jcin.2013.06.015. PMID: 24355117 Free article.

Ultrasound-guided thrombin injection for treatment of femoral artery pseudoaneurysm with concomitant AV-fistula – a retrospective single centre experience.
Steppich B, Schürmann F, Bruskina O, Hadamitzky M, Kastrati A, Schunkert H, Fusaro M, Ott I. Vasa. 2018 Oct;47(6):507-512. doi: 10.1024/0301-1526/a000732. Epub 2018 Sep 3. PMID: 30175945

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
Schüpke S, Neumann FJ, Menichelli M, Mayer K, Bernlochner I, Wöhrle J, Richardt G, Liebetrau C, Witzenbichler B, Antoniucci D, Akin I, Bott-Flügel L, Fischer M, Landmesser U, Katus HA, Sibbing D, Seyfarth M, Janisch M, Boncompagni D, Hilz R, Rottbauer W, Okrojek R, Möllmann H, Hochholzer W, Migliorini A, Cassese S, Mollo P, Xhepa E, Kufner S, Strehle A, Leggewie S, Allali A, Ndrepepa G, Schühlen H, Angiolillo DJ, Hamm CW, Hapfelmeier A, Tölg R, Trenk D, Schunkert H, Laugwitz KL, Kastrati A; ISAR-REACT 5 Trial Investigators. N Engl J Med. 2019 Oct 17;381(16):1524-1534. doi: 10.1056/NEJMoa1908973. Epub 2019 Sep 1. PMID: 31475799

Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial.
Schulz-Schüpke S, Helde S, Gewalt S, Ibrahim T, Linhardt M, Haas K, Hoppe K, Böttiger C, Groha P, Bradaric C, Schmidt R, Bott-Flügel L, Ott I, Goedel J, Byrne RA, Schneider S, Burgdorf C, Morath T, Kufner S, Joner M, Cassese S, Hoppmann P, Hengstenberg C, Pache J, Fusaro M, Massberg S, Mehilli J, Schunkert H, Laugwitz KL, Kastrati A; Instrumental Sealing of Arterial Puncture Site—CLOSURE Device vs Manual Compression (ISAR-CLOSURE) Trial Investigators. JAMA. 2014 Nov 19;312(19):1981-7. doi: 10.1001/jama.2014.15305. PMID: 25399273

Endovascular therapy of subclavian artery occlusive disease involving the vertebral artery origin.
Schneider V, Dirschinger R, Wustrow I, Müller A, Cassese S, Fusaro M, Kastrati A, Koppara T, Bergmann K, Laugwitz KL, Ibrahim T, Bradaric C. Vasa. 2020 Apr;49(3):205-213. doi: 10.1024/0301-1526/a000842. Epub 2020 Jan 6. PMID: 31904303

Rotational Atherectomy or Balloon-Based Techniques to Prepare Severely Calcified Coronary Lesions.
Rheude T, Fitzgerald S, Allali A, Mashayekhi K, Gori T, Cuculi F, Kufner S, Hemetsberger R, Sulimov DS, Rai H, Ayoub M, Bossard M, Xhepa E, Fusaro M, Toelg R, Joner M, Byrne RA, Richardt G, Kastrati A, Cassese S, Abdel-Wahab M. JACC Cardiovasc Interv. 2022 Sep 26;15(18):1864-1874. doi: 10.1016/j.jcin.2022.07.034. PMID: 36137691 Clinical Trial.
15
Super high-pressure balloon versus scoring balloon to prepare severely calcified coronary lesions: the ISAR-CALC randomised trial.
Rheude T, Rai H, Richardt G, Allali A, Abdel-Wahab M, Sulimov DS, Mashayekhi K, Ayoub M, Cuculi F, Bossard M, Kufner S, Xhepa E, Kastrati A, Fusaro M, Joner M, Byrne RA, Cassese S. EuroIntervention. 2021 Aug 27;17(6):481-488. doi: 10.4244/EIJ-D-20-01000. PMID: 33258774 Free PMC article.

ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized Trial.
Ott I, Cassese S, Groha P, Steppich B, Voll F, Hadamitzky M, Ibrahim T, Kufner S, Dewitz K, Wittmann T, Kasel AM, Laugwitz KL, Schunkert H, Kastrati A, Fusaro M. J Am Heart Assoc. 2017 Jul 25;6(7):e006321. doi: 10.1161/JAHA.117.006321. PMID: 28743787 Free PMC article. Clinical Trial.
17
Parallel suture technique with ProGlide: a novel method for management of vascular access during transcatheter aortic valve implantation (TAVI).
Ott I, Shivaraju A, Schäffer NR, Frangieh AH, Michel J, Husser O, Hengstenberg C, Mayr P, Colleran R, Pellegrini C, Cassese S, Fusaro M, Schunkert H, Kastrati A, Kasel AM. EuroIntervention. 2017 Oct 20;13(8):928-934. doi: 10.4244/EIJ-D-16-01036. PMID: 28606889